Biblio
Export 407 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is O [Clear All Filters]
“In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 465-471, 2017.
, “Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 253-262, 2017.
, “INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 58, no. 3, pp. 687-694, 2017.
, “INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 58, no. 3, pp. 687-694, 2017.
, “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
, “Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures.”, J Alzheimers Dis, vol. 57, no. 1, pp. 305-315, 2017.
, “An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 231-248, 2017.
, “Iron Concentration in Deep Gray Matter Structures is Associated with Worse Visual Memory Performance in Healthy Young Adults.”, J Alzheimers Dis, vol. 59, no. 2, pp. 675-681, 2017.
, “Job Loss After Diagnosis of Early-Onset Dementia: A Matched Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1231-1235, 2017.
, “Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 885-896, 2017.
, “A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.”, J Alzheimers Dis, vol. 60, no. 3, pp. 829-841, 2017.
, “Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1549-1570, 2017.
, “Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.”, J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
, “Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.”, J Alzheimers Dis, vol. 60, no. 1, pp. 273-281, 2017.
, “Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.”, J Alzheimers Dis, vol. 60, no. 2, pp. 401-425, 2017.
, “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
, “Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1089-1097, 2017.
, “Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1089-1097, 2017.
, “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
, “Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).”, J Alzheimers Dis, vol. 59, no. 2, pp. 707-721, 2017.
, “A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.”, J Alzheimers Dis, vol. 58, no. 2, pp. 389-400, 2017.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.”, J Alzheimers Dis, vol. 59, no. 1, pp. 313-328, 2017.
, “People with Dementia Can Learn Compensatory Movement Maneuvers for the Sit-to-Stand Task: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 1, pp. 107-120, 2017.
,